ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N03AX12 | G | Gabapentin - 400mg | 6569 | 218591/10 | NEUROPLEX | 400mg | 50 | Capsule | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 1,290,089 L.L | 23.08 | A2 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N03AX12 | G | Gabapentin - 400mg | 9798 | 122818/1 | GABAMOX | 400mg | 60 | Capsule, hard | Oral | New Allpharma | Farmalabor Produtos Farmaceuticos SA | Portugal | 1,233,647 L.L | 23.08 | A2 | Penta Farma | Portugal | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 400mg | 6312 | 24971/07 | GABANET 400 | 400mg | 48 | Capsule | Oral | C. Catafago & Co | The Jordanian Pharmaceutical Manufacturing Co. (JPM) | Jordan | 1,607,236 L.L | 23.08 | B | The Jordanian Pharmaceutical Manufacturing & Co Ltd | Jordan | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 400mg | 8705 | 85316/1 | GABAPENTINE ARROW GENERIQUES | 400mg | 90 | Capsule | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 1,342,499 L.L | 23.08 | A2 | Arrow Génériques | France | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 400mg | 6621 | 24990/07 | GABATREX | 400mg | 50 | Capsule | Oral | Abela Frères S.A.L. | Hikma Pharmaceuticals | Jordan | 1,846,440 L.L | 23.08 | B | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
N03AX12 | G | Gabapentin - 400mg | 6327 | 167453/10 | PMS-GABAPENTIN | 400mg | 50 | Capsule | Oral | UPO S.A.L. | Pharmascience Inc | Canada | 1,071,042 L.L | 23.08 | A2 | Pharmascience Inc | Canada | 2/5/2024 | 0 |